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Abstract
The bacterial transposon Tn7 is distinguished by its ability to recognize a specific site called attTn7, and insert just
downstream of the highly conserved chromosomal glmS gene. TnsD is one of four transposon-encoded polypep-
tides (TnsABC+D) required for site-specific insertion of Tn7 into attTn7, and is the target site-selector that binds to a
highly conserved sequence in the end of the glmS protein coding region. In this study, we identified important
nucleotides within this region that are crucial for TnsD-attTn7 interaction. We also probed the regions of TnsD that
interact with attTn7 and found that there are important DNA-binding determinants throughout the entire length
of the protein, including an amino-terminal CCCH zinc-finger motif. A key role of TnsD is to recruit the non-
sequence specific DNA-binding protein TnsC to attTn7; TnsC also interacts with and controls both the TnsA and
TnsB subunits of the Tn7 transposase. TnsC stimulates the binding of TnsD to attTn7 in vivo, and TnsCD and TnsD
can also interact in the absence of DNA and localize their interaction domains to the N-terminal region of each
protein.
Background
Tn7 i sav e r yd i s t i n c t i v eb a c t e r i a lt r a n s p o s o nt h a t
encodes five transposition proteins: Tns A, B, C, D and
E [1]. Strikingly, whereas most transposons insert rela-
tively randomly into many different sites, Tn7 transposi-
tion is quite specific. TnsD and TnsE are alternative
target site-selectors that direct Tn7 transposition into
either of two different target DNAs [2]: a very specific
chromosomal attachment site or DNAs undergoing
DNA replication [3].
When TnsD is the target selector, Tn7 inserts at high
frequency into a specific chromosomal site called an
attachment site, attTn7 [4]. Insertion occurs directly
downstream of the essential glmS gene, ensuring that it
does not disrupt the glmS open reading frame and glmS
expression is preserved [5]. Thus, Tn7 can access this
highly conserved ‘safe haven’ insertion site with no
obvious fitness costs to the host. Tn7 inserts into
attTn7 because TnsD specifically recognizes highly con-
served sequences within the protein coding region of
glmS [4], and recruits the rest of the transposition
machinery to this site.
The TnsD binding site in Escherichia coli glmS occu-
pies the last 36 bp of the glmS O R F[ 6 ] .T n s Da l s ob i n d s
the human glmS homologs gfpt-1 and gfpt-2 [7]. GlmS
(L-glucosamine–fructose-6-phosphate aminotransferase)
is highly conserved and found in a wide variety of organ-
isms from bacteria to humans [7]. The TnsD binding
region of glmS encodes the active site region of GlmS,
and this amino acid sequence is nearly completely (100%
conserved) in all organisms [8]. Indeed, most of the DNA
sequence divergence results from variation at the wobble
position of each codon (see below). Intriguingly, no parti-
cular DNA sequence other than the TnsD binding site is
apparently required for attTn7 function, even though the
actual point of Tn7 insertion is about 25 bp downstream
of the TnsD binding site. Changing this region in E. coli
attTn7 [9] does not change Tn7 insertion frequency, and
the sequences at the point of Tn7 insertion in attTn7::
Tn7 sites in other bacteria are also distinct [10]. Further-
more, the human glmS homologs gfpt-1 and gfpt-2 are
efficient targets for Tn7 insertion despite their different
sequences downstream of the GlmS ORF [7]. Thus, all
the sequence information necessary for Tn7 insertion in
attTn7 is apparently conferred by TnsD binding to the
end of glmS.
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protein. It has no homologs outside of Tn7-type trans-
posons, about 130 of which are now reported in Gen-
bank. When TnsD binds to attTn7,a n o t h e rT n s
protein, TnsC, is recruited [6], forming a TnsCD-attTn7
complex. DNA footprinting reveals that the TnsCD
complex on attTn7 extends from the TnsD binding site
to the point of Tn7 insertion that lies about 20 bp
downstream of the stop codon of glmS in an intergenic
region. Understanding how TnsD works is key to a
detailed understanding of how the unique transposon
Tn7 functions.
In this paper, we present results that provide insight
into TnsD interactions with its attTn7 DNA-binding
site and how TnsD functions to recruit its partner
attTn7 binding protein TnsC. We determined the
nucleotides that are important for TnsD binding in the
glmS gene using both in vitro and in vivo assays. Our
studies also revealed that in addition to binding to
DNA, TnsD interacts with TnsC independently from
interactions with attTn7. We also identified key amino
acids in TnsD for DNA binding and important regions
in TnsD for protein-protein interactions with TnsC.
Finally, we characterized dominant-negative mutants of
TnsD, which suggest that important interaction
domains are distributed throughout the protein. The
data show TnsD as a highly complex DNA-binding
protein that regulates TnsC activity to activate Tn7
transposition.
Results
Defining important base pairs in the TnsD binding site
Tn7 insertion occurs by the attack of the 3’OH ends of
Tn7 on staggered positions on the top and bottom
strands in attTn7, and DNA repair of the resulting gaps,
which results in 5 bp attTn7 duplications flanking the
newly inserted Tn7. Throughout this paper, the middle
base pair of this duplication sequence is designated ‘0’,
sequences that lie to the right towards glmS as ‘+’,a n d
those to the left as ‘-’; thus the Tn7 target site duplica-
tion is attTn7 -2 to +2. The minimal E. coli 36 bp
TnsD-binding site that has been defined by footprinting
studies extends from attTn7 +23 to +58, and can pro-
mote maximum insertion activity in vivo and in vitro
(Figure 1) [6]. TnsD also binds to the human glmS
homologs gfpt-1 and gfpt-2 [7], the Drosophila homologs
gfat-1 and gfat-2,a n dt h ez e b r a f i s hgfpt-1 (see Addi-
tional file 1).
The 36 bp TnsD-binding site lies within the 3’ end of
glmS, which encodes the C-terminus of the protein.
This region includes the GlmS active site and is highly
conserved at the protein level. We aligned this 36 bp
sequence from 25 bacterial glmS genes that have a
downstream Tn7 family transposon (GenBank) and the
homologous Drosophila, zebrafish and human genes
using the Sequence Logo algorithm [11] to generate a
consensus for the attachment site (Figure 1). Not sur-
prisingly for a region that encodes a highly conserved
protein, the first two positions at each codon are highly
+23 +58
TnsD binding region
P EVTVSKALN R stop
glmS amino acid sequence
Consensus attTn7
Point of Tn7 insertion
-2 +2
+25 +43 +40 +37 +34 +31 +28 +58 +55 +52 +49 +46
glmS
N C
*
Figure 1 The organization of attTn7. A schematic representation of the attTn7 at the C-terminus of the glmS gene with the TnsD binding site
is shown. The sequence of the E. coli GlmS protein (asterisk indicates the only amino acid within this 11 amino acid region that is not 100%
conserved within all 25 glmS sequences examined), and the consensus attTn7 sequence were derived as described in the text (note that the
least conserved nucleotides correspond to the third position of each codon).
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ble’ position.
Reasoning that TnsD would contact with the most
highly conserved bases within this region, we mutated
each of the most conserved bases in the E. coli attTn7
sequence (+23 ® +58) (Figure 1, Figure 2A) to the
opposite type (that is, pyrimidines to purines (e.g., cyto-
sine to adenine) and purines to pyrimidines (e.g., gua-
nine to thymine)). We performed gel-shift assays using
purified TnsD and radiolabeled attachment-site oligonu-
cleotides, and compared the relative amount of TnsD-
attTn7 complex formation of the mutants with that of
the wild-type attachment site (Figure 2A). Mutations at
positions attTn7 +31, +33, +42, +43, +45, +51 and +54
all had strong negative effects; that is, they resulted in a
reduction in binding of at least five-fold, indicating that
t h o s ep o s i t i o n sa r ev e r yi m p o r t a n tf o rT n s Db i n d i n gt o
attTn7. More modest (about two-fold) reductions in
attTn7 binding activity resulted from mutation at
attTn7 +30, +37, +48, +51 and +52.
We also examined the binding of TnsD to wild-type
and representative mutant attTn7 sites in vivo (Table 1).
W eu s e dt h eP 2 2c h a l l e n g ep h a g ea s s a yf o rD N Ab i n d -
ing in Salmonella, which has been used to identify and
characterize DNA-binding sites and protein-DNA inter-
actions in a wide variety of bacterial and eukaryotic
DNA-binding proteins [12]. Briefly, the anti-repressor of
lysogeny (ant) gene of phage P22 controls the choice
between P22 lysis and lysogeny upon infection. If ant is
expressed, the phage grows lytically, whereas if expres-
sion of ant is blocked, lysogeny can be established. The
expression of ant can be blocked by engineering the
binding site for a heterologous DNA-binding protein
(here attTn7), upstream of ant and providing the cog-
nate binding protein (here TnsD), in trans. If binding of
the tested protein to the introduced site occurs, expres-
sion of ant is blocked and lysogeny ensues, which can
be scored by the number of kanamycin-resistant colo-
nies, as the P22 genome imparts kanamycin resistance
to the cell. Thus, P22 lysogeny can be a measure of pro-
tein binding; lysogeny reflects binding of TnsD, whereas
if TnsD does not bind, ant is expressed and the phage
grows lytically.
We know from previous work that Tn7 transposition
functions well in Salmonella [13]. For the challenge
phage experiment, we constructed a P22 phage with
the E. coli attTn7 attachment site (+23 ® +58)
upstream of ant, thus putting the choice of lysogenic
vs lytic growth under the control of TnsD binding to
attTn7:i fT n s Db i n d s ,l y s o g e n ys h o u l do c c u r .W e
infected a Salmonella enterica Typhimurium strain
containing a plasmid-borne isopropyl b-D-1-thiogalac-
topyranoside (IPTG)-inducible tnsD gene with the
challenge phage carrying the E. coli attachment site
upstream of ant. The frequency of lysogenization of
the attTn7 phage increased more than 100-fold in the
presence of TnsD (Table 1). Thus the challenge phage
assay can be successfully used to evaluate TnsD bind-
ing to attTn7 in vivo. When assayed, the frequency of
lysogeny of a phage containing a wild-type attachment
site (+23 ® +58) was several orders of magnitude
higher than the frequency of lysogeny of phages con-
taining any of four mutant attachment sites that bind
TnsD poorly in vitro (Table 1). These assays show that
TnsD also binds poorly to these mutant sites in vivo,
supporting the view that the identity of these positions
is important for the site-specific binding activity of
TnsD.
attTn7 mutations that block TnsD binding also block Tn7
transposition in vivo
As described above, mutations in attTn7 can block
TnsD binding both in vitro and in vivo.W ea l s od e t e r -
mined the effect of attTn7 mutations on Tn7 insertion
into attTn7 in vivo in E. coli. In these assays, Tn7 trans-
position into a target plasmid containing attTn7 was
evaluated using a ‘l-hop’ assay [14], in which cells con-
taining a plasmid(s) expressing TnsABC+D were
infected with a replication- and integration-defective
lambda phage derivative carrying a miniTn7 kanamycin
resistance cassette (miniTn7-Kan
R), and the frequency
of miniTn7 insertion into the attTn7 plasmid was mea-
sured as the fraction of infected cells that became kana-
mycin-resistant.
We found that mutations that significantly (> 10-fold)
decreased TnsD binding to attTn7 also decreased Tn7
transposition in vivo by at least 100-fold (Figure 2C).
Thus, attTn7 +31, +33, +42, +43, +45 and +51 are key
positions for TnsD-attTn7 interaction. attTn7 sequence
changes that had more modest effects on TnsD binding,
(reductions of two- to five-fold), also reduced transposi-
tion by two- to five-fold. Thus, attTn7 +28, +30, +37,
+46, +48 and +54 also make contributions to TnsD-
attTn7 interaction.
Crosslinking of attTn7 to TnsD
Crosslinking studies with radiolabeled attTn7 DNA were
also used to further probe TnsD-attTn7 interaction.
Each ‘T’ on both strands of the attachment site was
individually replaced with iodouracil, then the attTn7
derivatives were tested for binding to TnsD by bandshift
assay and crosslinking was performed in the presence of
UV light. None of these iodouracil substitutions had a
detectable effect on TnsD binding in vitro (data not
shown). Of all of the positions tested, only IdUs at posi-
tions at attTn7 +23, +51 and +52 were in sufficiently
close proximity to TnsD to produce covalent protein-
DNA bonds in this assay (Figure 3); in all these cases,
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Page 3 of 14t h ec r o s s l i n k a b l eb a s ew a so nt h et o ps t r a n do fattTn7.
As described above, mutation alterations of the attach-
ment site at both attTn7 +51 and +52 had a negative
effect on TnsD binding to attTn7. These results suggest
that there are important base-specific contacts between
attTn7 and TnsD at these positions. By contrast, muta-
tion of the crosslinkable position attTn7 +23 had no
effect on TnsD binding or target activity in vivo.I t
should be noted that in such an assay, crosslinking
requires several different amino acids to be juxtaposed,
thus a failure to observe crosslinking does not mean
that TnsD is not immediately adjacent to DNA at these
positions, but rather that no crosslinkable amino acids
are nearby.
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Figure 2 attTn7 target activity. (A) The E. coli attTn7 sequence from +23 to +59 is shown; nucleotides that are highly conserved and
subsequently analyzed by mutation are boxed. (B) Graphical representation of the relative target DNA binding activity of TnsD on the mutant
attTn7 site in vitro is shown. Double stranded oligonucleotides with indicated mutations listed were used in gel-shift assays with TnsD. (C)
Graphical representation of the relative in vitro transposition activity on the mutant attTn7 site in vitro is shown. The activity of mutant attTn7
containing plasmid as a target for attTn7 transposition was measured using the lambda hop assay. The activity of wt attTn7 is 2 × 10
-4 and the
activity of mutants were normalized to this value.
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binding
Before the modern era of extensive bacterial genome
sequencing, Tn7,w h i c hw a si d e n t i f i e di nE. coli [15,16],
was unique. Now there are many examples in GenBank
of Tn7 relatives in a variety of different bacteria that con-
tain obvious TnsD homologs (Figure 4, Figure 5, Figure
6). The most notable feature of this alignment is a highly
conserved N-terminal region of about 170 amino acids
that contains a CCCH motif characteristic of zinc-finger
proteins [17]. In E. coli Tn7 TnsD, the motif consists of
Cys
124, Cys
127, Cys
152 and His
155 (Figure 4).
To determine directly whether TnsD binding to
attTn7 is dependent on zinc, gel-shift assays were
performed using wild-type TnsD and attTn7 in the
presence of increasing amounts of the zinc chelator
1,10-phenanthroline. Complex formation was severely
diminished by 2 mM 1,10-phenanthroline, indicating
that TnsD DNA binding is zinc-dependent (Figure 7).
We also individually mutated Cys124, Cys127, Cys152
and His155 to serine, and analyzed the ability of these
mutants to bind attTn7 in vitro and to promote trans-
position in vivo (Table 2). When purified, none of the
mutant TnsD proteins were able to bind attTn7 (Table
2). We again used the ‘l-hop’ assay to assay transposi-
tion of a miniTn7-Kan
R [14] from the infecting phage
into an attTn7 plasmid, by measuring the fraction of
infected cells that become kanamycin-resistant. The fre-
quency of transposition frequency promoted by the TnsD
zinc-finger mutants was reduced 1000-fold from that of
wild-type cells. Sequencing of junctions of independent
insertions from the in vivo transposition assay showed that
Tn7 insertions were present in attTn7 in a sequence- and
orientation-specific manner, with the 5-bp target duplica-
tion characteristic of Tn7 transposition, as occurs with
wild-type TnsD (data not shown). Thus, the insertions
recovered, although occurring at very low frequency, were
probably TnsD-mediated transposition events. As
described in more detail below, we were unable to observe
DNA binding in vitro with various N-terminal fragments
of TnsD, thus could not identify a discrete zinc finger
motif-containing DNA-binding domain.
TnsD has important DNA-binding determinants
throughout the protein
In an attempt to identify directly the domains of TnsD
involved in DNA binding, we generated a number of
TnsD deletion derivatives, and assessed DNA binding of
these mutants in vivo and in vitro. All tested C-terminal
deletion derivatives, (TnsD1 to 350, 1 to 399, 1 to 480,
1 to 490 and 1 to 498) were unable to bind DNA as
evaluated by in vitro band-shift assays and by in vivo
challenge phage assays (data not shown). However,
these truncated proteins did retain the ability to interact
with TnsC, indicating that they were not simply
unfolded (we discuss interaction of TnsD with TnsC
below). These observations suggest that in addition to
the zinc finger, TnsD contains DNA-binding determi-
nants spread across the entire length of the protein and
that several of these are required for attTn7 binding.
We were unable to detect interaction of N-terminal
TnsD truncations with TnsC or to purify these proteins
(data not shown).
Isolation of TnsD dominant-negative mutations
In another approach to identify the functional regions of
TnsD, we conducted a screen for mutations in TnsD that
have dominant-negative effects on TnsD-dependent
Table 1 TnsD binding to attTn7 in vivo
attTn7
position
Lysogeny frequency
a
TnsD
induced
TnsD
uninduced
+23 ® +58(wt) 7.4 × 10
-5 5.4 × 10
-7
+31 C®A 5.2 × 10
-9 -
+42 T®G 3.6 × 10
-8 -
+43 T®G 1.6 × 10
-8 -
+51 T®G 5.2 × 10
-9 -
aChallenge assay phages carrying the indicated mutations in attTn7 were
infected into cells expressing TnsD and the frequency of lysogeny measured;
values are the average of three independent infections performed in parallel
and relative to the wild type.
Modified base position
Crosslinked
TnsD-attTn7
     DNA
attTn7
IdU position
attTn7
Top strand
 +52  +60  +51  +44  +43  +42  +23
Figure 3 Crosslinking between TnsD and attTn7. Thymine was
replaced with iodouracil (IdU) and photocrosslinked to TnsD,
followed by SDS-PAGE. Free and bound DNA are indicated for
different positions along the attachment site.
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Page 5 of 14Figure 4 Multiple sequence alignment of TnsD proteins. An alignment of 11 different TnsD proteins (produced using the software T-Coffee;
http://www.ebi.ac.uk/t-coffee) showing the highly conserved CCCH zinc finger motif and the isolated dominant-negative mutants with reference
to E. coli TnsD protein, amino acid positions 1 to 213.
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Page 6 of 14Figure 5 Multiple sequence alignment of TnsD proteins. An alignment of 11 different TnsD proteins (produced using the software T-Coffee;
http://www.ebi.ac.uk/t-coffee) showing the isolated dominant-negative mutants with reference to E. coli TnsD protein, amino acid positions 214
to 323.
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tive mutants include those able to bind attTn7 but
unable to interact with TnsC, and also mutants unable to
bind attTn7 but able to interact with TnsC. We used a
promoter capture (papillation) assay as described by
Stellwagen and Craig[18], in which a miniTn7 containing
ap r o m o t e r l e s slac gene is mobilized from a plasmid
donor to chromosomal pseudo-attTn7 sites; attTn7 itself
was blocked by another Tn7 element. TnsABC+D were
expressed from a pACYC plasmid. Productive hops pro-
duce Lac
+ cells that form papillae on Lac
- colonies on
MacConkey lactose plates. To look for dominant-nega-
tives, we used hydroxylamine to mutate a pUC-based
TnsD gene, transformed it into the assay strain contain-
ing wild-type TnsABC+D, and looked for transformants
on MacConkey lactose plates within decreased numbers
of papillae. After hydroxylamine mutagenesis of TnsD
and screening of 15,000 transformants, we isolated 16
TnsD mutants, 11 of which were missense mutants and
five of which were nonsense mutants yielding truncated
TnsD; only two mutants (TnsD
P147L and TnsD
R276C )
were isolated twice (Figure 4, Figure 5, Figure 6).
We also quantitatively evaluated the effect of the domi-
nant-negative TnsD mutants on transposition. Using the
l hop assay, we assayed miniTn7-Kan
R insertion into
chromosomal attTn7 in the presence of pACYC TnsABC
Figure 6 Multiple sequence alignment of TnsD proteins. An alignment of 11 different TnsD proteins (produced using the software T-Coffee;
http://www.ebi.ac.uk/t-coffee) showing the isolated dominant-negative mutants with reference to E. coli TnsD protein, amino acid positions 324
to 507.
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Page 8 of 14+D and a pUC-based plasmid containing the TnsD
mutants (Table 3). In this assay, all of the dominant-
negative mutants identified by the papillation screen with
the exception of TnsD C447Y inhibited TnsABC+D
transposition at least 10-fold, confirming that they were
indeed dominant-negatives. Although the dominant-
negative effect of TnsD C447Y was more modest, this
may reflect the fact that the insertion targets are different
in these assays: the papillation assay measures insertion
into pseudo-attTn7 sites, whereas the l-hop assay mea-
sures insertion into chromosomal attTn7.
We also examined the ability of the dominant-negative
TnsD mutants to promote transposition in the presence
of TnsABC alone to determine if they possess residual
TnsD activity. All had substantial defects in TnsD
activity, with reductions ranging from at least 2.5-fold to
100-fold compared with wild-type cells.
Using the challenge phage assay, we also evaluated the
ability of most of the dominant-negative TnsD missense
mutants to bind to attTn7 in vivo,a n df o u n dt h a ta l l
were significantly reduced in their ability to bind attTn7
(Table 3). Using purified TnsD, we also found that all
t h em i s s e n s em u t a n t se x c e pt C447Y had significantly
impaired attTn7 binding in vitro (Table 3).
TnsC increases the binding of TnsD to attTn7
TnsC and TnsD form a novel complex with attTn7 in
vitro, and the presence of TnsC increases the amount of
protein-DNA complex formed [6]. We also used the
c h a l l e n g ep h a g ea s s a yt oe x a m i n et h eT n s C - T n s D -
attTn7 interaction in vivo (Table 4). TnsC does not pro-
mote the formation of lysogens on its own, as expected
given its non-specific DNA-binding activity [19]. How-
ever, when TnsC and TnsD were expressed simulta-
neously in the host cells, we observed a enhancement of
lysogeny of nearly 100-fold relative to cells expressing
only TnsD. Thus, TnsC considerably enhances TnsD
binding to attTn7 both in vivo and in vitro.
Although the binding of wild-type TnsD to attTn7 is
stimulated by TnsC, incubation with TnsC did not ‘res-
cue’ the formation of TnsCD-attTn7 complexes with the
dominant-negative missense mutant TnsD in vitro (data
not shown).
TnsC and TnsD can interact in the absence of attTn7
Previous studies revealed that a key determinant in the
recruitment of TnsC to TnsD-attTn7 is a distortion intro-
duced by TnsD into attTn7, which provides a binding site
for TnsC [6]. We have now found, using a yeast two-
hybrid assay, that TnsC and TnsD also interact directly in
the absence of attTn7 [20,21] (Table 5). The interaction
between full-length TnsC and TnsD is only slightly less
than that of the robust interaction displayed by the Fos-
Jun control, but equivalent to that of RB and E2F1 [22].
As determined by analysis of a series of C-terminal
deletion derivatives, the amino-terminal amino acid
sequence (1 to 309) of TnsD retain full binding to TnsC
in this assay and thus contains the determinants for
TnsD binding to TnsC. The isolation of the TnsD trun-
cation sequence (1 to 340; full-length TnsD is 507 aa) as
a dominant negative is consistent with this hypothesis
(see below). However, if as few as seven amino acids are
removed from the N-terminus of TnsD, the TnsC-TnsD
interaction is disrupted (data not shown). The lack of
activity of TnsD sequence 1 to 436, even though both
longer and shorter constructs are active, may be due to
inappropriate folding or to the unmasking of an inhibi-
tory domain.
TnsD-attTn7
 attTn7
  1     2     5    10    20   0
  
TnsD
1, 10 Phenanthroline
 (mM)
  
-
  
+
  
+
  
+
  
+
  
+
  
+
Figure 7 Chelation of zinc using 1,10-phenanthroline
eliminates TnsD binding to attTn7 DNA.
Table 2 Targeted mutations to the conserved CCCH
residues in TnsD eliminates Tn7 transposition and TnsD-
attTn7 binding
Protein Relative attTn7
binding in vitro
Relative transposition
frequency in vivo
TnsD wt 1.0 1.0
a
TnsD C124S 0.05 < 0.001
TnsD C127S 0.05 < 0.001
TnsD C152S 0.05 < 0.001
TnsD C155S 0.05 < 0.001
aThe transposition frequency in the presence of TnsD wt is 7.8 × 10
-4.
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the yeast two-hybrid system (Table 5). TnsC-TnsD
interaction with TnsD is maintained with deletion of 75
or 171 amino acids from the C terminus of TnsC (full-
length is 555 aa), but a deletion of 223 amino acids
leads to loss of the interaction with TnsD (Table 5);
thus interaction of TnsC with TnsD occurs within the 1
to 293 region of TnsC. The finding that Tn7 inserts at
high-frequency in attTn7 using TnsC 86 to 555 (Spen-
cer J and NLC, unpublished observation) suggests that
the TnsD interaction domain lies within TnsC 1 to 293.
Discussion
The sequence-specific binding of TnsD to the 3’ end of
the coding region of the glmS gene is sufficient to
prompt the site - and orientation-specific insertion of
Tn7 to a position about 20 bp downstream of glmS,t h a t
i s ,t op r o d u c eaf u n c t i o n a lattTn7 site [23]. Previous
work in vitro identified the 36 bp span of the TnsD
binding site, and demonstrated that this sequence alone
is sufficient to direct transposition [6]. In this study, we
have further probed the interaction of TnsD with
attTn7 and deepened our understanding of Tn7 site-
specific insertion. Our results have revealed that deter-
minants of the interaction of TnsD with attTn7 extend
throughout the TnsD protein and the TnsD binding site.
The amino acid sequence of the C-terminus of vir-
tually all GlmS proteins is identical. Comparison of the
TnsD binding site in attTn7 sites from a variety of bac-
teria and several eukaryotes revealed that 19 of the 35
bp were completely conserved, and correspond to non-
wobble positions for each codon at the glmS terminus.
Analysis of TnsD binding and transposition to these
mutant sites with substitutions at each of these con-
served positions revealed that changes at seven (attTn7
+31, +33, +42, +43, +45, +51 and +54) had significant
effects on TnsD binding and Tn7 transposition. Model-
ing of the attachment site as B-form DNA (Figure 8)
indicates that the important nucleotides are on one face
Table 3 Dominant-negative mutants of TnsD
From dominant-negative TnsD screen
a Relative transposition in
presence of
Relative attTn7 binding in vivo
d Relative attTn7 binding in vitro
TnsD proteins TnsABC
b TnsABC
c
No TnsD 1.00 0 < 0.00001 -
TnsD WT 1.00 1.13 1.0 1.0
TnsD A18T 0.05 0.01 - -
TnsD P82L 0.05 0.01 - -
TnsD M96I 0.10 0.30 0.005 0.3
TnsD G109E 0.07 < 0.001 0.0006 0.05
TnsD P147L 0.05 < 0.001 0.0016 0.07
TnsD R276C 0.04 < 0.001 - -
TnsD H287Y 0.06 < 0.001 - -
TnsD P417L 0.08 0.04 0.0014 0.07
TnsD C447Y 0.10 0.40 0.012 0.7
TnsD A486H 0.06 0.04 - 0.1
TnsD A497I 0.06 0.04 0.0005 0.05
Truncations
TnsD Q227Z 0.05 < 0.001 - -
TnsD Q305Z 0.03 < 0.001 - -
TnsD Q306Z 0.03 < 0.001 - -
TnsD Q340Z 0.04 < 0.001 0.0004 < 0.05
TnsD W371Z 0.08 < 0.001 - < 0.05
aThese substitutions and truncations were isolated as dominant negatives and then analysed for transposition in vivo and DNA binding in vivo and in vitro.
bTn7 transposition frequency in vivo was measured using the lambda hop assay and carried out in presence of TnsABCD + TnsD (dominant-negative mutants).
cTn7 transposition frequency in vivo was measured using the lambda hop assay and was carried out in presence of TnsABC + TnsD (dominant-negative mutants).
dThe binding of mutant TnsDs to attTn7 in vivo was measured using the challenge phage assay.
Table 4 TnsC increases TnsD binding to attTn7 in vivo
Tns protein Lysogeny frequency
a
TnsC < 8.0 × 10
-7b
TnsD 2.4 × 10
-3
TnsC + TnsD 2.4 × 10
-1
aUsing the in vivo challenge phage assay, adding TnsC to TnsD increased
lysogeny, also indicating that TnsC is stabilizing TnsD on the DNA. TnsC alone
did not increase lysogeny.
bLowest possible measurement in this assay.
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Page 10 of 14of the DNA. This is consistent with the crosslinking
data presented here, in which contacts with the major
groove were detected (Figure 3), and with previous
DNA footprinting studies showing that TnsD makes
major groove contacts [6].
The activity of attTn7 is strongly directional: Tn7
always inserts downstream of the glmS termination
codon, mediated by activation of a TnsCD-attTn7 com-
plex that promotes orientation-specific insertion of Tn7.
Consistent with this asymmetric pattern of insertion,
attTn7 does not contain inverted repeats for the binding
of an oligomeric TnsD.
Previous studies have shown that a key step in Tn7
insertion into attTn7 is the ability of TnsD to introduce
a DNA distortion(s) into attTn7,w h i c hw eh a v ep r o -
posed prompts the binding of TnsC, the regulator of the
TnsAB transposase [6,24]. In addition to providing a
higher resolution view of TnsD-attTn7 interaction, we
also identified a previously unknown interaction pro-
tein-protein interaction between TnsC and TnsD. Deter-
minants for this interaction are located within the N-
terminal region of TnsD covering positions 1 to 309 and
the N-terminal region of TnsC covering positions 1 to
293. It seems likely that the DNA-mediated and pro-
tein-protein interactions are both important to TnsC-
mediated activation of transposition.
TnsC also interacts with and activates both subunits
of the Tn7 transposase (TnsA and TnsB), which mediate
breakage and joining of the ends of Tn7 [25]. TnsA, the
transposase subunit that cleaves at the 5’ ends of Tn7,
and TnsC form a TnsA2C2 complex in solution,
mediated by interactions between the N-terminal region
of TnsA and the 50 carboxy-terminal amino acids of
TnsC [26]. A distinct TnsACD complex has also been
observed [27], which we suggested is the ‘target’ DNA
complex, with which the TnsB transposase subunit med-
iates breakage and joining at the 3’ ends of the transpo-
son [28]. The other transposase subunit TnsB binds
specifically to the ends of Tn7, and mediates breakage
and joining at the 3’ ends [29]. Interactions between
TnsC and the C-terminus of TnsB have also been
detected [30]. The apposition of the TnsACD-attTn7
and TnsB-Tn7 end complexes results in the assembly
Table 5 Yeast 2 hybrid assay shows that TnsC and TnsD
can interact in vivo
Protein fragment b-galactosidase activity
Fos Jun 5.0
E2F1 RB 1.0
Empty vector
Gal4-AD
Empty vector
Gal4-DB
0.075
TnsC (1 to 555) wt TnsD (1 to 507) wt 1.0
TnsC (1 to 555) wt TnsD (1 to 436) 0.075
TnsC (1 to 555) wt TnsD (1 to 399) 4.5
TnsC (1 to 555) wt TnsD (1 to 375) 5.0
TnsC (1 to 555) wt TnsD (1 to 350) 4.5
TnsC (1 to 555) wt TnsD (1 to 309)
a 4.5
TnsC (1 to 555) wt TnsD (1 to 293) 0.075
TnsC (1 to 555) wt TnsD (8 to 507) 0.075
TnsC (1 to 555) wt TnsD (12 to 507) 0.075
TnsC (1 to 555) wt TnsD (16 to 507) 0.075
TnsC (1 to 555) wt TnsD (22 to 507) 0.075
TnsC (1 to 555) wt TnsD (1 to 507) wt 1.0
TnsC (1 to 480) TnsD (1 to 507) wt 1.0
TnsC (1 to 384) TnsD (1 to 507) wt 1.0
TnsC (1 to 332) TnsD (1 to 507) wt 0.20
TnsC (1 to 293)
a TnsD (1 to 507) wt 0.20
TnsC (1 to 280) TnsD (1 to 507) wt 0.014
aDeletion analysis of TnsD and TnsC revealed that this protein-protein
interaction activity is contained within TnsC 1 to 293 and TnsD 1 to 309.
   Tn7 
insertion +31+33 +42 +43 +45 +51
-2 +2 +25
distortion
TnsD attachment site
attTn7
Figure 8 DNA model of attTn7. A model of the attachment site, showing the minimum attTn7 site region required for TnsD binding in green,
important bases (of one strand) in purple, unimportant sequence in gray, and the target duplication site in red. Phosphates are marked for
clarity, although binding is probably dependent on base interactions, not sugar-backbone interactions.
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to learned about the mechanism by which TnsD-attTn7
activates TnsC and hence TnsAB.
Functional domains of TnsD
TnsD is a multifunctional protein: it binds specifically
to attTn7 and, as we have shown here, interacts with its
partner in transpositon, TnsC. In this study, we have
made considerable progress in understanding the
unique TnsD family of DNA-binding proteins by defin-
ing important protein determinants for DNA binding
and transposition, and key nucleotides for the TnsD-
attTn7 interaction. Although we identified a zinc finger
motif in the N-terminal region of TnsD, we were unable
to use deletion analysis to identify a functional discrete
DNA-binding domain(s). It is possible there are multi-
ple DNA-binding domains throughout the protein, a
model consistent with the fact that the region of TnsD
interaction with DNA spans about 35 bp. However, we
were able to use deletion analysis to localize the TnsC-
interaction region of TnsD to its N-terminal amino
acids 1 to 309, and the TnsD-interaction region of
TnsC to its amino acids 1 to 293. Although our ability
to isolate TnsD dominant negatives is consistent with
this protein being multifunctional, our inability to
further identify crucial subregions within TnsD pre-
cludes definitive conclusions of the physical basis of the
dominant negatives.
As previously proposed, the ability of TnsD to direct
transposition to a defined sequence makes it an attrac-
tive candidate for use in targeted delivery of DNA
sequences for genetic manipulation in organisms from
bacteria to human [7,13]. Further structure-function
analyses of TnsD will not only facilitate a deeper under-
standing of Tn7 transposition but also the use of Tn7
and TnsD as tools for genomic engineering.
Methods
Bacterial strains, plasmids and phages
CAG456 is E. coli (SC122 htpR165) [32]. NLC51 is E.
coli F
-araD139 Δ(argF-lac)U169 rpsL150 relA1 flbB5301
deoC1 ptsF25 rbsR valR recA56 [33]. BD409 is a deriva-
tive of E. coli CW51 with att::promoterless lacZY
flanked by Tn7 transposon end sequences sufficient for
transposition: 166 bp from the left end of Tn7(Tn7L)
a n d9 0b pf r o mt h er i g h te n do f( T n 7R) [4,34]. Plasmid
pMR1 was constructed by PCR amplifying the tnsD
gene from pCW4 [4] and cloning it into pCYB1 digested
with NcoI and SapI (New England Biolabs, Ipswich, MA,
USA.). pCW4 was used as a source of TnsABCD and
pCW15 as a source of TnsABC in the in vivo transposi-
tion assays [4]. pCW23 was used for mutating tnsD [4].
Phage KK1, used as the source of Tn7 transposon in the
l-hop assay, is a derivative of 780 (b2::hisOGD b522
cI857 Pam80 nin5)w i t hhisG9424::Tn10 del16 del17::
attTn7(-342 to +165)::miniTn7kan
R [35].
Affinity purification of intein-TnsD
The full length TnsD wild-type and mutant proteins
were purified as intein fusions from CAG456 contain-
ing plasmid pRM1 or mutant TnsD derivative plas-
mids. Site-directed mutations in tnsD were generated
by PCR (QuickChange Site Directed Mutagenesis Sys-
tem; Agilent Technologies) and verified by direct DNA
sequencing. Representative cells were grown at 30°C to
an OD600 = 0.5 in Luria broth supplemented with 100
mg/ml carbenicillin, IPTG was added to give 0.4 mM
final concentration, and the cells were allowed to grow
for an additional 4 h. All subsequent steps were per-
formed at 4°C unless otherwise stated. The cells were
separated by centrifugation, and resuspended in the
buffer supplied with the kit (Buffer A; 50 mM HEPES
pH 8, 500 mM NaCl, 10% v/v glycerol). The cells were
then lysed by sonication and separated by centrifuga-
tion at 26,000 g for 30 min, the resulting supernatant
was then filtered through a 0.45 μm syringe filter (Nal-
g e n e ,R o c h e s t e r ,N Y ,U S A ) .T h ef i l t r a t ew a sa p p l i e dt o
pre-equilibrated chitin beads (New England Biolabs) in
a 10 ml column and the beads then washed several
times (5×) in Buffer A. The washed chitin beads were
then treated with Buffer B (50 mM HEPES pH 8, 500
m MN a C l ,1 0 %v / vg l y c e r o l ,1 0m MM g C l 2,1 0m M
ATP) for 1 h at room temperature to remove residual
GroEL protein. The beads were then washed with sev-
eral volumes of buffer B at 4°C (2×), and incubated
overnight with Buffer C (50 mM HEPES pH 8, 500
mM NaCl, 10% v/v glycerol, 50 mM dithiothreitol
(DTT)), which promotes cleavage of TnsD from the
intein tag [36,37]. Full-length TnsD was then eluted
from the column using Buffer C without DTT, and
peak fractions were pooled, dialyzed against another
b u f f e r( 5 0 0m MK C l ,5 0m MT r i s - H C l( p H8 . 0 ) ,1m M
EDTA, 2 mM DTT and 25% v/v glycerol), then stored
at -80°C.
Isolation of dominant-negative tnsD mutants
pCW23 (TnsD) [4] was treated with 1 M hydroxylamine
hydrochloride in NaOH at 37°C for 24 h. The mutagen
was dialyzed out of the DNA in Tris-EDTA buffer. The
DNA was recovered by ethanol precipitation, and trans-
formed into BD409 carrying wild-type tnsABCD on a
compatible plasmid, pCW4 [4]. Transformants were pla-
ted onto MacConkey lactose plates containing appropri-
ate antibiotics. The plates were incubated at 30°C for 5
days, and transformants were screened for decreased
papillation (to Lac
+). Plasmid DNA was extracted from
these potential mutants and transformed into the same
strain background to verify the papillation phenotype.
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recloned for expression.
l hop assay
The transposition frequency of a miniTn7kan
R element
from the integration- and replication-defective phage
KK1 into the chromosomal attTn7 site of E. coli strain
NLC51 and a plasmid containing the attTn7 site of E.
coli strain LA3 was evaluated when Tns proteins were
supplied in trans [35,38] The transposition frequency
was the number of kanamycin-resistant colonies per
plaque-forming unit.
DNA-binding reactions
Binding reactions were performed with wild-type and
mutant versions of TnsD proteins and wild-type TnsC
protein as described previously [6].
Protein-DNA UV photo-crosslinking reaction
Protein-DNA crosslinking was performed as described
previously [39].
. Oligonucleotides were synthesized
(Eurofins MWG Operon, Huntsville, AL, USA) with
dT replaced by IdU. Double-stranded (ds)DNAs were
then formed by gradual annealing with a complemen-
tary oligonucleotide, and then radio-labeled with
5' phosphorylation.
For crosslinking reactions, 25 pmol TnsD and 0.5
pmol attTn7 dsDNA were incubated in solution (25
mM HEPES, 2.5 mM TrisCl, 40 mM DTT, 0.005% BSA
and 50 ng/ul herring sperm DNA, pH 7.5) for 20 min at
30°C. Photo-crosslinking was then carried out with UV
irradiation at 312 nm (StrataLinker; Agilent Technolo-
g i e s ,L aJ o l l a ,C A ,U S A )f o r3 0m i n .T h er e a c t i o nw a s
s e tu ps ot h a tt h et o po ft h eo p e n1 . 5m lE p p e n d o r f
tube touched the UV tube. After UV crosslinking, the
reaction was analyzed by SDS-PAGE.
Yeast two-hybrid assay
The yeast two-hybrid assay was performed according to
the manufacturer’s protocol (Proquest Two-Hybrid Sys-
tem; Life Technologies Inc., Carlsbad, CA, USA). TnsD
was cloned into pDBLeu (Life Technologies Inc) and
TnsC into pPC86 (Life Technologies Inc). b-galactosi-
dase assays were performed as described previously [40].
In vitro transposition reactions
Inv i t r otransposition reactions were performed essen-
tially as described previously [19]. The donor plasmid
pEMΔ (5.9 kb) contains a 1.6 kb miniTn7kan
R element.
The 3.2 kb target plasmid pRM2 [35] contains a 555 bp
attTn7 segment (-342 to +165). Reaction mixtures (100
μl final volume) contained 0.25 nM pEM donor DNA,
2.5 nM pRM2 target plasmid, 28 mM HEPES pH 8.0,
2.2 mM DTT, 4.4 mM Tris pH 7.5, 100 mg/ml tRNA,
50 mg/ml bovine serum albumin (BSA), 0.16 mM
EDTA, 0.1 mM MgCl2, 0.1 mM CHAPS detergent, 30
mM NaCl, 21 mM KCl, 1.8% v/v glycerol, 2.0 mM ATP
and 15 mM MgOAc unless otherwise indicated. Tns
proteins were added as follows: 40 ng TnsA, 25 ng
TnsB, 30 ng TnsC and 22 ng TnsD. Reaction mixtures
containing all components except donor DNA, TnsA,
TnsB and MgOAc were assembled on ice. The assembly
reaction mixtures were incubated for 20 min at 30°C;
donor DNA, TnsA, TnsB and MgOAc were then added,
and the incubation was continued for an additional 20
min. Reactions were stopped by adjusting to 25 mM
EDTA, followed by extraction with phenol:chloroform
(1:1). The DNA was then precipitated with ethanol,
digested with NdeI and separated in a 0.6% agarose gel,
with electrophoresis carried out at 50 V for 16 h. The
DNAs were transferred to a hybridization membrane
(Gene Screen Plus; PerkinElmer, Foster City, CA, USA)
and hybridized with a probe specific for miniTn7kan
R.
The probe was labeled by random priming with
32P-
dCTP and the Klenow fragment of DNA polymerase I
(Boehringer Mannheim Biochemicals (BMB), Indianapo-
lis, IN, USA). All blots were analyzed using a phosphor-
escent imager (PhosphorImager; Molecular Dynamics,
Sunnyvale, CA, USA).
Challenge phage assays
Challenge phages were constructed as described in [12].
The wild-type attTn7 attachment site attTn7 (+23 ® +58)
w a sc l o n e di na so l i g o n u c l e o t i d e s( 5 ’-CCGCGTA-
ACCTGGCAAAATCGGTTACGGTTGAGTAA-3’ and
the complementary oligonucleotide into the SmaIs i t eo f
pPY190, creating pGRG60). All mutant attachment sites
were variants of that sequence (as described in the text).
The challenge phage assay was carried out as described
previously [12], using plasmid pCYB1-TnsD or mutant
variants of that plasmid to express TnsD, selecting for
kanamycin-resistant P22 lysogens. Expression of TnsD
proteins was induced with 1 mM IPTG. Results are
expressed in lysogens/cell. TnsC was expressed constitu-
tively from pGRG63, a plasmid constructed by cutting
pCW15[4] with SapIa n dBstXI, blunting and religating
the plasmid, to eliminate the TnsAB genes.
Additional material
Additional file 1: TnsD protein binds to attTn7-like sequences
within the glmS analog of Drosophila gfat-1, and the gfat-2 and
glmS analog of zebrafish gfpt-1.
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